Silverfin false false 30/11/2023 30/11/2023 01/12/2022 no description of principal activity Catherine Elaine Dale 10/08/2010 Dr Mark Christopher Dale 09/02/2009 06813914 2023-11-30 06813914 bus:Director1 2023-11-30 06813914 bus:Director2 2023-11-30 06813914 2022-11-30 06813914 core:CurrentFinancialInstruments 2023-11-30 06813914 core:CurrentFinancialInstruments 2022-11-30 06813914 core:Non-currentFinancialInstruments 2023-11-30 06813914 core:Non-currentFinancialInstruments 2022-11-30 06813914 2022-12-01 2023-11-30 06813914 bus:Micro-entities 2022-12-01 2023-11-30 06813914 bus:FilletedAccounts 2022-12-01 2023-11-30 06813914 bus:AuditExemptWithAccountantsReport 2022-12-01 2023-11-30 06813914 bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 06813914 bus:Director1 2022-12-01 2023-11-30 06813914 bus:Director2 2022-12-01 2023-11-30 06813914 2021-12-01 2022-11-30 iso4217:GBP xbrli:pure

Company No: 06813914 (England and Wales)

CLINISAFE LIMITED

UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 30 NOVEMBER 2023
PAGES FOR FILING WITH THE REGISTRAR

CLINISAFE LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 30 NOVEMBER 2023

Contents

CLINISAFE LIMITED

COMPANY INFORMATION

FOR THE FINANCIAL YEAR ENDED 30 NOVEMBER 2023
CLINISAFE LIMITED

COMPANY INFORMATION (continued)

FOR THE FINANCIAL YEAR ENDED 30 NOVEMBER 2023
DIRECTORS Catherine Elaine Dale
Dr Mark Christopher Dale
REGISTERED OFFICE 19 Park Road
Lytham St. Annes
FY8 1PW
United Kingdom
COMPANY NUMBER 06813914 (England and Wales)
ACCOUNTANT MHA Moore and Smalley
Chartered Accountants
Richard House
9 Winckley Square
Preston
PR1 3HP
CLINISAFE LIMITED

BALANCE SHEET

AS AT 30 NOVEMBER 2023
CLINISAFE LIMITED

BALANCE SHEET (continued)

FOR THE FINANCIAL YEAR ENDED 30 NOVEMBER 2023
2023 2022
£ £
Current assets 16,979 4,701
Creditors: amounts falling due within one year - ( 3,514)
Net current assets 16,979 1,187
Total assets less current liabilities 16,979 1,187
Creditors: amounts falling due after more than one year ( 470,543) ( 455,844)
Accruals and deferred income ( 1,500) ( 1,500)
Net liabilities ( 455,064) ( 456,157)
Capital and reserves ( 455,064) ( 456,157)

For the financial year ending 30 November 2023 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Clinisafe Limited (registered number: 06813914) were approved and authorised for issue by the Board of Directors on 21 March 2024 and were signed on its behalf by:

Dr Mark Christopher Dale
Director
CLINISAFE LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 30 NOVEMBER 2023
CLINISAFE LIMITED

NOTES TO THE FINANCIAL STATEMENTS (continued)

For the FOR THE FINANCIAL YEAR ENDED 30 NOVEMBER 2023

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 06813914). The address of its registered office is 19 Park Road, Lytham St. Annes, FY8 1PW, United Kingdom.

2. Employees

2023 2022
Number Number
Monthly average number of persons employed by the Company during the financial year, including directors 2 2